Green tea consumption may prevent, treat prostate cancer
the ONA take:
According to a new study published in the journal The Prostate, brewed green tea may have a role a in the prevention and treatment of prostate cancer and other prostate conditions like prostatitis.
For the exploratory, open label, phase 2 study, researchers sought to investigate the effect of green tea and black tea consumption on prostate cancer biomarkers.
They enrolled 113 men with prostate cancer and randomly assigned them to consume six cups daily of brewed green tea, black tea, or water before undergoing a radical prostatectomy. Of the 113 patients enrolled, 93 completed the study. Results showed no significant difference in biomarkers that measure proliferation, apoptosis, or oxidation in radical prostatectomy tissue among the three groups.
A biomarker that measures inflammation, called NFκB was significantly lower in the tissue of men that consumed green tea compared with those who consumed water (P = 0.013), but there was no difference between black tea and water (P = 0.931). In addition, nearly all of the men who consumed green tea had tea polyphenols detected in their prostate tissue, but no men who consumed black tea were found to have the chemicals.
Furthermore, those who consumed green tea had evidence of a systemic antioxidant effect (P = 0.03) and a small but statistically significant PSA level reduction (P = 0.04). The findings suggest that further studies to examine the effect of green tea on prostate cancer prevention and treatment are warranted.
Green tea may have a role a in the prevention and treatment of prostate cancer and other prostate conditions like prostatitis.
- Novel Colonoscopy Prep Is Poised to Improve Screening Rates for Colon Cancer
- PPIs Negatively Impact Outcomes of Patients Treated With Capecitabine
- How Physical Changes From Breast Cancer Affect Self-Image: Considerations for Clinicians
- Clinical Use of Cabozantinib in the Treatment of Advanced Kidney Cancer: Efficacy, Safety, and Patient Selection
- Panobinostat Modestly Improves OS in Relapsed Multiple Myeloma
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Sugar and Cancer: Mitigating the Affects of Diet on Cancer
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Implementing a Distress Screening Process for Cancer Patients
- Initiating Palliative Care in the Emergency Department
- Pseudohyperkalemia: False Potassium Levels Occur in a Patient With Lymphoma
- Atezolizumab Granted FDA Approval for Specific Cases of NSCLC
- Low-Dose Sublingual Fentanyl Safe, Effective in Patients Receiving Lower Opioid Doses
- High U.S. Economic Burden for Vaccine-Preventable Diseases
- Short-Term Intervention May Have Long-term Diet Effect in Hispanic Breast Cancer Survivors
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|